Nociceptin and its metabolite attenuate U0126-induced memory impairment through a nociceptin opioid peptide (NOP) receptor-independent mechanism

Masaya Miwa, Shogo Uchida, Fumika Horiba, Hiroshi Takeshima, Toshitaka Nabeshima, Masayuki Hiramatsu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Nociceptin binds to nociceptin opioid peptide (NOP) receptors. We reported that although high doses of nociceptin impaired memory function and that these effects were mediated via NOP receptors, low doses of nociceptin attenuated the memory impairment, and these attenuating effects were not mediated via NOP receptors. Even very low doses of nociceptin were biologically active and suggested a certain binding site for this peptide, but the mechanism underlying this attenuating effect has not yet been elucidated. In the present study, we investigated the effect of an intrahippocampal injection (i.h.) of nociceptin on memory impairment induced by U0126, a MEK inhibitor, and Rp-cAMPS, a PKA inhibitor in a step-down type passive avoidance test. U0126 (2.63. nmol/mouse, i.h.) impaired memory formation and training-dependent phosphorylation of ERK2 in the hippocampus. Co-administration of nociceptin (10. fmol/mouse) significantly attenuated memory impairment, while it did not attenuate the inhibition of training-dependent phosphorylation of ERK2 induced by U0126. On the other hand, nociceptin did not attenuate memory impairment induced by Rp-cAMPS (0.448. nmol/mouse, i.h.). Nociceptin (1. fmol/mouse) also attenuated U0126 (5.26. nmol/mouse)-induced memory impairment in NOP receptor knockout mice. Nociceptin was reported to metabolize into fragments (1-13) and (14-17) in vivo, which showed pharmacological activities without affecting NOP receptors. Our findings showed that nociceptin (14-17) (1. fmol/mouse) also attenuated U0126-induced memory impairment, while nociceptin (1-13) (0.1-10. fmol/mouse) did not attenuate memory impairment. These results suggest a novel action site or mechanism for the attenuating effects of nociceptin and its metabolite, and the sequence of nociceptin (14-17) is a critical structure.

Original languageEnglish
Pages (from-to)396-405
Number of pages10
JournalNeurobiology of Learning and Memory
Volume93
Issue number3
DOIs
Publication statusPublished - 01-03-2010

Fingerprint

Peptide Receptors
Opioid Peptides
Opioid Receptors
nociceptin
U 0126
Injections
Phosphorylation
Mitogen-Activated Protein Kinase Kinases

All Science Journal Classification (ASJC) codes

  • Experimental and Cognitive Psychology
  • Cognitive Neuroscience
  • Behavioral Neuroscience

Cite this

Miwa, Masaya ; Uchida, Shogo ; Horiba, Fumika ; Takeshima, Hiroshi ; Nabeshima, Toshitaka ; Hiramatsu, Masayuki. / Nociceptin and its metabolite attenuate U0126-induced memory impairment through a nociceptin opioid peptide (NOP) receptor-independent mechanism. In: Neurobiology of Learning and Memory. 2010 ; Vol. 93, No. 3. pp. 396-405.
@article{c77279ba6c8a457aacb3904bece7decb,
title = "Nociceptin and its metabolite attenuate U0126-induced memory impairment through a nociceptin opioid peptide (NOP) receptor-independent mechanism",
abstract = "Nociceptin binds to nociceptin opioid peptide (NOP) receptors. We reported that although high doses of nociceptin impaired memory function and that these effects were mediated via NOP receptors, low doses of nociceptin attenuated the memory impairment, and these attenuating effects were not mediated via NOP receptors. Even very low doses of nociceptin were biologically active and suggested a certain binding site for this peptide, but the mechanism underlying this attenuating effect has not yet been elucidated. In the present study, we investigated the effect of an intrahippocampal injection (i.h.) of nociceptin on memory impairment induced by U0126, a MEK inhibitor, and Rp-cAMPS, a PKA inhibitor in a step-down type passive avoidance test. U0126 (2.63. nmol/mouse, i.h.) impaired memory formation and training-dependent phosphorylation of ERK2 in the hippocampus. Co-administration of nociceptin (10. fmol/mouse) significantly attenuated memory impairment, while it did not attenuate the inhibition of training-dependent phosphorylation of ERK2 induced by U0126. On the other hand, nociceptin did not attenuate memory impairment induced by Rp-cAMPS (0.448. nmol/mouse, i.h.). Nociceptin (1. fmol/mouse) also attenuated U0126 (5.26. nmol/mouse)-induced memory impairment in NOP receptor knockout mice. Nociceptin was reported to metabolize into fragments (1-13) and (14-17) in vivo, which showed pharmacological activities without affecting NOP receptors. Our findings showed that nociceptin (14-17) (1. fmol/mouse) also attenuated U0126-induced memory impairment, while nociceptin (1-13) (0.1-10. fmol/mouse) did not attenuate memory impairment. These results suggest a novel action site or mechanism for the attenuating effects of nociceptin and its metabolite, and the sequence of nociceptin (14-17) is a critical structure.",
author = "Masaya Miwa and Shogo Uchida and Fumika Horiba and Hiroshi Takeshima and Toshitaka Nabeshima and Masayuki Hiramatsu",
year = "2010",
month = "3",
day = "1",
doi = "10.1016/j.nlm.2009.12.006",
language = "English",
volume = "93",
pages = "396--405",
journal = "Neurobiology of Learning and Memory",
issn = "1074-7427",
publisher = "Academic Press Inc.",
number = "3",

}

Nociceptin and its metabolite attenuate U0126-induced memory impairment through a nociceptin opioid peptide (NOP) receptor-independent mechanism. / Miwa, Masaya; Uchida, Shogo; Horiba, Fumika; Takeshima, Hiroshi; Nabeshima, Toshitaka; Hiramatsu, Masayuki.

In: Neurobiology of Learning and Memory, Vol. 93, No. 3, 01.03.2010, p. 396-405.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Nociceptin and its metabolite attenuate U0126-induced memory impairment through a nociceptin opioid peptide (NOP) receptor-independent mechanism

AU - Miwa, Masaya

AU - Uchida, Shogo

AU - Horiba, Fumika

AU - Takeshima, Hiroshi

AU - Nabeshima, Toshitaka

AU - Hiramatsu, Masayuki

PY - 2010/3/1

Y1 - 2010/3/1

N2 - Nociceptin binds to nociceptin opioid peptide (NOP) receptors. We reported that although high doses of nociceptin impaired memory function and that these effects were mediated via NOP receptors, low doses of nociceptin attenuated the memory impairment, and these attenuating effects were not mediated via NOP receptors. Even very low doses of nociceptin were biologically active and suggested a certain binding site for this peptide, but the mechanism underlying this attenuating effect has not yet been elucidated. In the present study, we investigated the effect of an intrahippocampal injection (i.h.) of nociceptin on memory impairment induced by U0126, a MEK inhibitor, and Rp-cAMPS, a PKA inhibitor in a step-down type passive avoidance test. U0126 (2.63. nmol/mouse, i.h.) impaired memory formation and training-dependent phosphorylation of ERK2 in the hippocampus. Co-administration of nociceptin (10. fmol/mouse) significantly attenuated memory impairment, while it did not attenuate the inhibition of training-dependent phosphorylation of ERK2 induced by U0126. On the other hand, nociceptin did not attenuate memory impairment induced by Rp-cAMPS (0.448. nmol/mouse, i.h.). Nociceptin (1. fmol/mouse) also attenuated U0126 (5.26. nmol/mouse)-induced memory impairment in NOP receptor knockout mice. Nociceptin was reported to metabolize into fragments (1-13) and (14-17) in vivo, which showed pharmacological activities without affecting NOP receptors. Our findings showed that nociceptin (14-17) (1. fmol/mouse) also attenuated U0126-induced memory impairment, while nociceptin (1-13) (0.1-10. fmol/mouse) did not attenuate memory impairment. These results suggest a novel action site or mechanism for the attenuating effects of nociceptin and its metabolite, and the sequence of nociceptin (14-17) is a critical structure.

AB - Nociceptin binds to nociceptin opioid peptide (NOP) receptors. We reported that although high doses of nociceptin impaired memory function and that these effects were mediated via NOP receptors, low doses of nociceptin attenuated the memory impairment, and these attenuating effects were not mediated via NOP receptors. Even very low doses of nociceptin were biologically active and suggested a certain binding site for this peptide, but the mechanism underlying this attenuating effect has not yet been elucidated. In the present study, we investigated the effect of an intrahippocampal injection (i.h.) of nociceptin on memory impairment induced by U0126, a MEK inhibitor, and Rp-cAMPS, a PKA inhibitor in a step-down type passive avoidance test. U0126 (2.63. nmol/mouse, i.h.) impaired memory formation and training-dependent phosphorylation of ERK2 in the hippocampus. Co-administration of nociceptin (10. fmol/mouse) significantly attenuated memory impairment, while it did not attenuate the inhibition of training-dependent phosphorylation of ERK2 induced by U0126. On the other hand, nociceptin did not attenuate memory impairment induced by Rp-cAMPS (0.448. nmol/mouse, i.h.). Nociceptin (1. fmol/mouse) also attenuated U0126 (5.26. nmol/mouse)-induced memory impairment in NOP receptor knockout mice. Nociceptin was reported to metabolize into fragments (1-13) and (14-17) in vivo, which showed pharmacological activities without affecting NOP receptors. Our findings showed that nociceptin (14-17) (1. fmol/mouse) also attenuated U0126-induced memory impairment, while nociceptin (1-13) (0.1-10. fmol/mouse) did not attenuate memory impairment. These results suggest a novel action site or mechanism for the attenuating effects of nociceptin and its metabolite, and the sequence of nociceptin (14-17) is a critical structure.

UR - http://www.scopus.com/inward/record.url?scp=77950689980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950689980&partnerID=8YFLogxK

U2 - 10.1016/j.nlm.2009.12.006

DO - 10.1016/j.nlm.2009.12.006

M3 - Article

C2 - 20026233

AN - SCOPUS:77950689980

VL - 93

SP - 396

EP - 405

JO - Neurobiology of Learning and Memory

JF - Neurobiology of Learning and Memory

SN - 1074-7427

IS - 3

ER -